TY - JOUR
T1 - Impact of micronutrient fortification of yoghurt on micronutrient status markers and growth - A randomized double blind controlled trial among school children in Bangladesh
AU - Sazawal, Sunil
AU - Habib, Akm Ahsan
AU - Dhingra, Usha
AU - Dutta, Arup
AU - Dhingra, Pratibha
AU - Sarkar, Archana
AU - Deb, Saikat
AU - Alam, Jahangir
AU - Husna, Asmaul
AU - Black, Robert E.
N1 - Funding Information:
We gratefully acknowledge the contributions of school children who participated in this study, their parents, study team, including development scientists, field workers, supervisors, physicians, data management and other support staff. We acknowledge contributions of GAIN-the Global Alliance for Improved Nutrition for funding the study and Grameen Danone Foods Ltd. Bogra, Bangladesh for providing yoghurt used in the trial. Contribution of Shilpi Gupta in editorial input and revision of manuscript are thankfully acknowledged. Supported by the Global Alliance for Improved Nutrition (GAIN).
PY - 2013
Y1 - 2013
N2 - Background: Interventions providing foods fortified with multiple micronutrients can be a cost-effective and sustainable strategy to improve micronutrient status and physical growth of school children. We evaluated the effect of micronutrient-fortified yoghurt on the biochemical status of important micronutrients (iron, zinc, iodine, vitamin A) as well as growth indicators among school children in Bogra district of Bangladesh. Methods. In a double-masked randomized controlled trial (RCT) conducted in 4 primary schools, 1010 children from classes 1-4 (age 6-9 years) were randomly allocated to receive either micronutrient fortified yoghurt (FY, n = 501) or non-fortified yoghurt (NFY, n = 509). For one year, children were fed with 60 g yoghurt everyday providing 30% RDA for iron, zinc, iodine and vitamin A. Anthropometric measurements and blood/urine samples were collected at base-, mid- and end-line. All children (FY, n = 278, NFY, n = 293) consenting for the end-line blood sample were included in the present analyses. Results: Both groups were comparable at baseline for socio-economic status variables, micronutrient status markers and anthropometry measures. Compliance was similar in both the groups. At baseline 53.4% of the population was anemic; 2.1% was iron deficient (ferritin <15.0 μg/L and TfR > 8.3 mg/L). Children in the FY group showed improvement in Hb (mean difference: 1.5; 95% CI: 0.4-2.5; p = 0.006) as compared to NFY group. Retinol binding protein (mean diff: 0.05; 95% CI: 0.002-0.09; p = 0.04) and iodine levels (mean difference: 39.87; 95% CI: 20.39-59.35; p < 0.001) decreased between base and end-line but the decrease was significantly less in the FY group. Compared to NFY, the FY group had better height gain velocity (mean diff: 0.32; 95% CI: 0.05-0.60; p = 0.02) and height-for-age z-scores (mean diff: 0.18; 95% CI: 0.02-0.33; p = 0.03). There was no difference in weight gain velocity, weight-for-age z-scores or Body Mass Index z-scores. Conclusion: In the absence of iron deficiency at baseline the impact on iron status would not be expected to be observed and hence cannot be evaluated. Improved Hb concentrations in the absence of a change in iron status suggest improved utilization of iron possibly due to vitamin A and zinc availability. Fortification improved height gain without affecting weight gain. Trial registration. ClinicalTrial.gov: NCT00980733.
AB - Background: Interventions providing foods fortified with multiple micronutrients can be a cost-effective and sustainable strategy to improve micronutrient status and physical growth of school children. We evaluated the effect of micronutrient-fortified yoghurt on the biochemical status of important micronutrients (iron, zinc, iodine, vitamin A) as well as growth indicators among school children in Bogra district of Bangladesh. Methods. In a double-masked randomized controlled trial (RCT) conducted in 4 primary schools, 1010 children from classes 1-4 (age 6-9 years) were randomly allocated to receive either micronutrient fortified yoghurt (FY, n = 501) or non-fortified yoghurt (NFY, n = 509). For one year, children were fed with 60 g yoghurt everyday providing 30% RDA for iron, zinc, iodine and vitamin A. Anthropometric measurements and blood/urine samples were collected at base-, mid- and end-line. All children (FY, n = 278, NFY, n = 293) consenting for the end-line blood sample were included in the present analyses. Results: Both groups were comparable at baseline for socio-economic status variables, micronutrient status markers and anthropometry measures. Compliance was similar in both the groups. At baseline 53.4% of the population was anemic; 2.1% was iron deficient (ferritin <15.0 μg/L and TfR > 8.3 mg/L). Children in the FY group showed improvement in Hb (mean difference: 1.5; 95% CI: 0.4-2.5; p = 0.006) as compared to NFY group. Retinol binding protein (mean diff: 0.05; 95% CI: 0.002-0.09; p = 0.04) and iodine levels (mean difference: 39.87; 95% CI: 20.39-59.35; p < 0.001) decreased between base and end-line but the decrease was significantly less in the FY group. Compared to NFY, the FY group had better height gain velocity (mean diff: 0.32; 95% CI: 0.05-0.60; p = 0.02) and height-for-age z-scores (mean diff: 0.18; 95% CI: 0.02-0.33; p = 0.03). There was no difference in weight gain velocity, weight-for-age z-scores or Body Mass Index z-scores. Conclusion: In the absence of iron deficiency at baseline the impact on iron status would not be expected to be observed and hence cannot be evaluated. Improved Hb concentrations in the absence of a change in iron status suggest improved utilization of iron possibly due to vitamin A and zinc availability. Fortification improved height gain without affecting weight gain. Trial registration. ClinicalTrial.gov: NCT00980733.
KW - Bangladesh
KW - Iodine
KW - Micronutrient fortification
KW - Retinol binding protein
KW - Zinc
UR - http://www.scopus.com/inward/record.url?scp=84878254585&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84878254585&partnerID=8YFLogxK
U2 - 10.1186/1471-2458-13-514
DO - 10.1186/1471-2458-13-514
M3 - Article
C2 - 23714325
AN - SCOPUS:84878254585
SN - 1471-2458
VL - 13
JO - BMC public health
JF - BMC public health
IS - 1
M1 - 514
ER -